(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

17 Suppliers, 11 USDMF, 5 CEP/COS, 3 EU WC, 6 NDC API, 6 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

3 Suppliers

3 Suppliers

DOSSIERs // Finished Dosage Forms

75 Dossiers, 20 FDA Orange Book, 34 Europe, 6 Canada, 4 Australia, 4 South Africa, 7 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 17.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 18 BASF, 14 Roquette, 8 Sigachi Industries, 7 Gangwal Healthcare, 7 DKSH, 6 Gangwal Chemicals, 4 ACG Worldwide, 4 Nanjing Well Pharmaceutical, 3 Microlex e.U, 3 Boai NKY Pharmaceuticals Ltd, 3 Pluviaendo, 3 Lonza Capsugel, 3 Kerry, 2 SPI Pharma, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Pharmatrans-Sanaq, 2 Nanjing Bold Chemical, 2 DFE Pharma, 2 Ulanqab Kema New Material, 1 Qualicaps, 1 Actylis, 1 Rochem International Inc, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Seppic, 1 Valens Pharmachem, 1 Novo Excipients, 1 Prachin Chemical, 1 Finar, 1 Ideal Cures Pvt Ltd, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

34 Fillers, Diluents & Binders, 22 Direct Compression, 22 Thickeners and Stabilizers, 16 Granulation, 15 Solubilizers, 11 Coating Systems & Additives, 10 Co-Processed Excipients, 8 Controlled & Modified Release, 8 Taste Masking, 8 Empty Capsules, 7 Topical, 7 Disintegrants & Superdisintegrants, 7 Film Formers & Plasticizers, 6 Parenteral, 5 Lubricants & Glidants, 4 Chewable & Orodispersible Aids, 3 Coloring Agents, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers, 1 Emulsifying Agents

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 19 Finished Drug Prices

MARKET PLACE

7 APIs, 3 DOSSIERS // FDF

REF. STANDARDS & IMPURITIES

2 EDQM, 3 USP, 3 Others

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 2 News

Pharmacy pricing data of (2e,4e,6e,8e)-9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic Acid obtained from U.S. Medicaid's National Average Drug Acquisition Cost

(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

17 Suppliers

11 USDMF

5 CEP/COS

3 EU WC

6 NDC API

6 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

3 Suppliers

DOSSIERs // Finished Dosage Forms

75 Dossiers

20 FDA Orange Book

34 Europe

6 Canada

4 Australia

4 South Africa

7 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 17.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

18 BASF

14 Roquette

8 Sigachi Industries

7 Gangwal Healthcare

7 DKSH

6 Gangwal Chemicals

4 ACG Worldwide

4 Nanjing Well Pharmaceutical

3 Microlex e.U

3 Boai NKY Pharmaceuticals Ltd

3 Pluviaendo

3 Lonza Capsugel

3 Kerry

2 SPI Pharma

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Pharmatrans-Sanaq

2 Nanjing Bold Chemical

2 DFE Pharma

2 Ulanqab Kema New Material

1 Qualicaps

1 Actylis

1 Rochem International Inc

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Seppic

1 Valens Pharmachem

1 Novo Excipients

1 Prachin Chemical

1 Finar

1 Ideal Cures Pvt Ltd

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

34 Fillers, Diluents & Binders

22 Direct Compression

22 Thickeners and Stabilizers

16 Granulation

15 Solubilizers

11 Coating Systems & Additives

10 Co-Processed Excipients

8 Controlled & Modified Release

8 Taste Masking

8 Empty Capsules

7 Topical

7 Disintegrants & Superdisintegrants

7 Film Formers & Plasticizers

6 Parenteral

5 Lubricants & Glidants

4 Chewable & Orodispersible Aids

CAPSULE;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 17.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 22.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons